O
Oorja Bio develops novel therapies targeting the underlying pathophysiology of cardiopulmonary and fibrotic disorders. Their medicines aim to promote cellular repair, reverse, and remodel diseased fibrotic tissue. The company seeks to establish a new standard of care beyond current symptom management approaches.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Oorja Bio develops novel therapies targeting the underlying pathophysiology of cardiopulmonary and fibrotic disorders. Their medicines aim to promote cellular repair, reverse, and remodel diseased fibrotic tissue. The company seeks to establish a new standard of care beyond current symptom management approaches.